BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28625522)

  • 1. Immunogenicity and therapeutic effects of recombinant Ag85AB fusion protein vaccines in mice infected with Mycobacterium tuberculosis.
    Liang Y; Zhang J; Yang Y; Bai X; Yu Q; Li N; Hou Y; Shi Y; Wang L; Wu X
    Vaccine; 2017 Jul; 35(32):3995-4001. PubMed ID: 28625522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and therapeutic effects of Ag85A/B chimeric DNA vaccine in mice infected with Mycobacterium tuberculosis.
    Liang Y; Wu X; Zhang J; Xiao L; Yang Y; Bai X; Yu Q; Li Z; Bi L; Li N; Wu X
    FEMS Immunol Med Microbiol; 2012 Dec; 66(3):419-26. PubMed ID: 23163873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapeutic efficacy of recombinant Mycobacterium smegmatis expressing Ag85B-ESAT6 fusion protein against persistent tuberculosis infection in mice.
    Wang P; Wang L; Zhang W; Bai Y; Kang J; Hao Y; Luo T; Shi C; Xu Z
    Hum Vaccin Immunother; 2014; 10(1):150-8. PubMed ID: 23982126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.
    Radosevic K; Wieland CW; Rodriguez A; Weverling GJ; Mintardjo R; Gillissen G; Vogels R; Skeiky YA; Hone DM; Sadoff JC; van der Poll T; Havenga M; Goudsmit J
    Infect Immun; 2007 Aug; 75(8):4105-15. PubMed ID: 17526747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapeutic effects of Mycobacterium tuberculosis rv3407 DNA vaccine in mice.
    Liang Y; Zhao Y; Bai X; Xiao L; Yang Y; Zhang J; Wang L; Cui L; Wang T; Shi Y; Zhao W; Wu X
    Autoimmunity; 2018 Dec; 51(8):417-422. PubMed ID: 30632804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG7909 adjuvant enhanced immunogenicity efficacy in mice immunized with ESAT6-Ag85A fusion protein, but does not confer significant protection against Mycobacterium tuberculosis infection.
    Hu S; Chen H; Ma J; Chen Q; Deng H; Gong F; Huang H; Shi C
    J Appl Microbiol; 2013 Nov; 115(5):1203-11. PubMed ID: 23902541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advax4 delta inulin combination adjuvant together with ECMX, a fusion construct of four protective mTB antigens, induces a potent Th1 immune response and protects mice against Mycobacterium tuberculosis infection.
    de Paula Oliveira Santos B; Trentini MM; Machado RB; Rúbia Nunes Celes M; Kipnis A; Petrovsky N; Junqueira-Kipnis AP
    Hum Vaccin Immunother; 2017 Dec; 13(12):2967-2976. PubMed ID: 28937879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
    Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B
    Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
    Deng YH; He HY; Zhang FJ
    Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of Homologous and Heterologous Prime-Boost Immunization Regimens of Recombinant Adenovirus and Modified Vaccinia Virus Ankara Expressing an Ag85B-TB10.4 Fusion Protein against
    Kou Y; Wan M; Shi W; Liu J; Zhao Z; Xu Y; Wei W; Sun B; Gao F; Cai L; Jiang C
    J Microbiol Biotechnol; 2018 Jun; 28(6):1022-1029. PubMed ID: 29847865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice.
    Yuan W; Dong N; Zhang L; Liu J; Lin S; Xiang Z; Qiao H; Tong W; Qin C
    Vaccine; 2012 Mar; 30(14):2490-7. PubMed ID: 21704108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-gamma confers effective protection against Mycobacterium tuberculosis in C57BL/6 mice.
    Xu Y; Zhu B; Wang Q; Chen J; Qie Y; Wang J; Wang H; Wang B; Wang H
    FEMS Immunol Med Microbiol; 2007 Dec; 51(3):480-7. PubMed ID: 17919299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of immunogenicity and protective efficacy against Mycobacterium tuberculosis infection elicited by recombinant Mycobacterium bovis BCG expressing human Interleukin-12p70 and Early Secretory Antigen Target-6 fusion protein.
    Deng Y; Bao L; Yang X
    Microbiol Immunol; 2011 Nov; 55(11):798-808. PubMed ID: 21831202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Bacillus subtilis spores for the delivery of Mycobacterium tuberculosis Ag85B-CFP10 secretory antigens.
    Das K; Thomas T; Garnica O; Dhandayuthapani S
    Tuberculosis (Edinb); 2016 Dec; 101S():S18-S27. PubMed ID: 27727129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and humoral immunogenicity of recombinant Mycobacterium smegmatis expressing Ag85B epitopes in mice.
    Kadir NA; Sarmiento ME; Acosta A; Norazmi MN
    Int J Mycobacteriol; 2016 Mar; 5(1):7-13. PubMed ID: 26927984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan microspheres enhance the immunogenicity of an Ag85B-based fusion protein containing multiple T-cell epitopes of Mycobacterium tuberculosis.
    Zhu Bd; Qie Yq; Wang Jl; Zhang Y; Wang Qz; Xu Y; Wang Hh
    Eur J Pharm Biopharm; 2007 Jun; 66(3):318-26. PubMed ID: 17280823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.
    Dai G; Rady HF; Huang W; Shellito JE; Mason C; Ramsay AJ
    Vaccine; 2016 Dec; 34(50):6267-6275. PubMed ID: 27823900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development and preliminary evaluation of a new Mycobacterium tuberculosis vaccine comprising Ag85b, HspX and CFP-10:ESAT-6 fusion protein with CpG DNA and aluminum hydroxide adjuvants.
    Chen L; Xu M; Wang ZY; Chen BW; Du WX; Su C; Shen XB; Zhao AH; Dong N; Wang YJ; Wang GZ
    FEMS Immunol Med Microbiol; 2010 Jun; 59(1):42-52. PubMed ID: 20298499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant BCG coexpressing Ag85B, ESAT-6 and Rv3620c elicits specific Th1 immune responses in C57BL/6 mice.
    Yang E; Lu Y; Xu Y; Liang Q; Wang C; Wang H; Shen H
    Microb Pathog; 2014; 69-70():53-9. PubMed ID: 24726737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel vaccine p846 encoding Rv3615c, Mtb10.4, and Rv2660c elicits robust immune response and alleviates lung injury induced by Mycobacterium infection.
    Kong H; Dong C; Xiong S
    Hum Vaccin Immunother; 2014; 10(2):378-90. PubMed ID: 24280763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.